Visp, Switzerland

Thomas Meul


 

Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Canton Valais, CH (1989)
  • Visp (Canton Valais), CH (1989)
  • Visp (Kanton Wallis), CH (1989)
  • Visp, CH (1986 - 2020)

Company Filing History:


Years Active: 1986-2020

Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Meul in the Pharmaceutical Field

Introduction

Thomas Meul, located in Visp, Switzerland, is an accomplished inventor with a remarkable portfolio of 30 patents. His work primarily focuses on innovative processes for synthesizing pharmaceutical compounds, demonstrating a significant contribution to the field of medicinal chemistry.

Latest Patents

Among his latest patents is the process for preparing salicyloyl-L-carnitine hydrochloride. This invention involves a method for synthesizing 3-(2-hydroxybenzoyloxy)-4-(trimethylammonio)butyrobetaine hydrochloride. The process comprises reacting 3-hydroxy-4-(trimethylammonio)butyrobetaine or a salt with a 2-alkoxybenzoyl chloride, where R can be benzyl or branched C3-C6 alkyl groups. Another notable patent is for the preparation of (-)-α-(difluoromethyl)ornithine-monohydrochloride monohydrate. This compound involves the separation of isomers using (-)-O,O’-di-p-toluoyl-L-tartaric acid, highlighting its role as an inhibitor of ornithine decarboxylase with potential pharmacological applications.

Career Highlights

Throughout his career, Thomas Meul has made significant strides in pharmaceutical innovation while working with leading companies such as Lonza Inc. and Drug'on Pharma Switzerland AG. His expertise in developing novel compounds has positioned him as a key player in the industry, contributing to advancements in therapeutic agents.

Collaborations

Thomas Meul has collaborated with notable professionals, including John McGarrity and Leander Tenud. These partnerships have fostered an environment of innovation, enabling the exchange of ideas and enhancing the scope of research within the pharmaceutical sector.

Conclusion

With his extensive patent portfolio and collaborative efforts, Thomas Meul continues to push the boundaries of pharmaceutical research. His inventions not only exemplify technical ingenuity but also promise to impact health care positively, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…